Autopsy report · NCT00334204
Does An Abnormal PFA 100 Predict Bleeding After Renal Biopsy?
Cause of deathFunding or business
“run out of independent funding”
Life of this trial
- Registered 1 year 10 months after it had already started.
- Ran for about 4 years 4 months before it stopped.
- 58 participants enrolled.
- Results were posted on the registry 4 years 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University of Mississippi Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Kidney Failure, Acute; Kidney Failure, Chronic; Blood Platelet Disorders; Hemorrhage
- Interventions
- measuring Platelet Function Analyser-100 (PFA-100) platelet function before kidney biopsy
- Participants
- 58
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery
“Ran out of funding” - Effects of Vigabatrin on Cocaine Self-Administration
“Funding ran out” - The Addition of Metformin to Definitive Radiotherapy in Patients With Stage III NSCLC
“Loss of external funding” - Effects of Amygdala Neurofeedback on Depressive Symptoms
“The grant funding ran out” - Antipsychotic Effects of Oxytocin
“Break in funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.